SURG vs TJGC

SURG exhibits critical financial distress, highlighted by a Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -0.91, indicating negative shareholder equity. While the company shows impressive top-line revenue growth of 68.70%, it is fundamentally broken, reporting a negative gross margin of -18.59%, meaning it loses money on every dollar of revenue generated. Severe liquidity risk is evident with a current ratio of 0.38, and a consistent track record of missing earnings estimates (0/4 in the last year) suggests a complete disconnect between analyst projections and operational reality.

TJGC exhibits severe financial distress, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic profit margin of -122.08%. While the current ratio of 2.61 suggests short-term liquidity, the company is losing money at the gross level (-12.96%), meaning its core business model is currently unsustainable. The stock has experienced a massive 85.3% decline over the past year, and the recent one-month price spike appears to be speculative volatility rather than a fundamental recovery. With no Graham Number or Intrinsic Value available due to negative earnings, the company presents a high-risk profile.